Elemental Iodine Or Iodine Compound Patents (Class 424/667)
-
Patent number: 12005132Abstract: This invention proposes a multifunctional topical composition that integrates halogen-functionalized fullerenes and metallic nanoparticles (NPs) to provide comprehensive skin protection and sanitizing, cosmetic enhancement, and in some embodiments, treatment for various conditions. Leveraging the atomic scale and physical characteristics of halogenated fullerenes for deeper tissue dispersion, the composition can provide antioxidant, antimicrobial, and UV protective benefits to foster cellular integrity, proliferation, and differentiation as healthy tissue. The proposed formulation can deliver active ingredients through the pores of sweat glands; the lipid matrix of the stratum corneum; and hair follicles, sebaceous glands, and pilosebaceous pores to then penetrate underlying dermal layers. This composition also uses stable, inorganic antibacterial agents with a robust safety profile.Type: GrantFiled: August 11, 2023Date of Patent: June 11, 2024Inventors: Terry Earl Brady, Anthony Lee Dellinger, Lowell Hughes, Lori Bush, Melinda K. M. Goddard, Abed Algader Ibrahim
-
Patent number: 11484035Abstract: The present invention provides a synergistic composition of a nematicide comprising of a nematicidal peptides derived from CED-4 protein sequence comprising of at least two peptides. The nematicidal peptides individually show 100% nematicidal activity at a concentration of 1 mg/ml, whereas, the combination of at least two peptides in a ratio of 1:1 shows 100% nematicidal activity at concentration as low as 0.8 mg/ml bringing a synergistic effect. This synergistic nematicidal composition is highly economical as it requires 20% less peptide concentration for 100% activity, moreover the composition is environmentally safe and non-toxic to humans and animals.Type: GrantFiled: March 17, 2018Date of Patent: November 1, 2022Assignee: TELLURIS BIOTECH INDIA PRIVATE LIMITEDInventors: Venu Polineni, Alejandro Calderón Urrea, Glenda W. Polack
-
Patent number: 11357952Abstract: A method of making a ready-to-use catheter assembly is provided, which can be immediately used by a patient. The ready-to-use catheter assembly ensures that the catheter does not suffer from a loss of quality during its shelf life and a wetting medium are provided. The method comprises: placing a catheter with an inactivated hydrophilic outer surface at least along its insertable length and a wetting medium in a catheter package; treating the catheter package with the catheter and the wetting medium with electro-magnetic and/or particle radiation while at least initially the hydrophilic outer surface at least along the insertable length of the catheter remains inactivated; and activating the hydrophilic outer surface at least along the insertable length of the catheter with the wetting medium during and/or after the radiation treatment and wherein the wetting medium decreases in viscosity when submitted to electro-magnetic and/or particle radiation.Type: GrantFiled: May 25, 2017Date of Patent: June 14, 2022Assignee: TELEFLEX LIFE SCIENCES PTE. LTD.Inventors: Katy Ryan, Ronald John Kelly, Morgan Tierney, David Scully, Alan Fitzgerald
-
Patent number: 11357876Abstract: Compositions that are suitable for use as a disinfectant are disclosed. Methods of making and using compositions that are suitable for use as a disinfectant are also disclosed.Type: GrantFiled: September 29, 2017Date of Patent: June 14, 2022Inventor: Mark Steven Moroney
-
Patent number: 11154564Abstract: The present invention relates to a new composition for use in the treatment of cough comprising one or more polysaccharide fractions of plantain, one or more polysaccharide fractions of marshmallow, honey, brown sugar, one or more polyphenolic fractions of agrimony comprising tannins.Type: GrantFiled: February 12, 2018Date of Patent: October 26, 2021Assignee: ABOCA S.P.A. SOCIETÀ AGRICOLAInventors: Valentino Mercati, Luisa Mattoli, Paola Polenzani
-
Patent number: 11077031Abstract: The present invention relates to: an oil-in-water emulsion composition having a viscosity of 1,500-50,000 cps, and comprising an anionic surfactant and a sugar surfactant so as to satisfy the following relational expression 1; and a cosmetic composition containing the same. [Relational expression 1] 0.01?A/B?1 (In relational expression 1, A is the wt % of the anionic surfactant, and B is the wt % of the sugar surfactant, wherein the wt % of each ingredient is based on the total weight of the composition, and B is 1-30 wt %.Type: GrantFiled: September 28, 2016Date of Patent: August 3, 2021Assignee: AMOREPACIFIC CORPORATIONInventors: Young Uk Cho, Byung Geun Chae, Sungil Park, Seong A Cho, Do Hoon Kim, Seung Han Park, Jae il Han
-
Patent number: 10590466Abstract: The present disclosure provides a composition comprising brazilein which can be used as a fluorescent dye for enhanced visualization of nucleic acids such as DNA, and RNA. Also provided in the specification is a simple, time and cost effective method of extraction of brazilein from bark starting material.Type: GrantFiled: June 23, 2016Date of Patent: March 17, 2020Assignee: Fathima Benazir Jahangir AliInventor: Fathima Benazir Jahangir Ali
-
Patent number: 9504255Abstract: The present invention relates to a physical antimicrobial method, which has the action of combating or inhibiting microorganisms when applied to the surface of human or animal body or an object. The method is safe for human body, and can prevent drug resistance caused by an antibacterial drug.Type: GrantFiled: July 16, 2013Date of Patent: November 29, 2016Assignee: NMS TECHNOLOGIES CO., LTD.Inventor: Youliang Cai
-
Publication number: 20150099011Abstract: A method of treating early papillomavirus infection of an orifice of a human or animal body including any canal associated with an orifice, comprising applying a viral inactivation agent to the orifice and/or canal in an amount effective to inactivate a portion of the virus infecting the orifice or canal. Apparatus is also disclosed.Type: ApplicationFiled: December 11, 2014Publication date: April 9, 2015Inventor: Jenny Colleen McCloskey
-
Patent number: 8993001Abstract: Methods for treating feline hyperthyroidism comprising (1) administering to a feline an antithyroid agent in conjunction with feeding the feline a composition comprising from about 0.1 to less than about 1 mg/kg iodine or (2) feeding the feline a composition comprising from about 0.1 to less than about 1 mg/kg selenium on a dry matter basis.Type: GrantFiled: January 26, 2007Date of Patent: March 31, 2015Assignee: Hill's Pet Nutrition, Inc.Inventors: Karen Joy Wedekind, Dale Allen Fritsch, Chadwick Everett Dodd, Timothy Arthur Allen
-
Patent number: 8951578Abstract: A compound of all natural ingredients allows for treatment of infected, inflamed, and sore hooves without the need for wrapping the hoof with a diaper or vet wrap as is conventional. The compound is packable into the bottom of a hoof. A sugar base allows the compound to stick to the underside of a hoof and remain applied without the wrap. Epsom salts and iodine provide antiseptic and antimicrobial properties, and pine tar provides moisture balance within the hoof in addition to supplementing the stickiness of the compound. Applied compound may be covered with a piece of paper or cloth.Type: GrantFiled: November 16, 2011Date of Patent: February 10, 2015Inventor: Ashley Kehoe
-
Publication number: 20150030701Abstract: Disclosed are compositions and methods for antimicrobial use. The compositions contain a small antimicrobial agent and a permeabilizing agent. The antimicrobial compositions can be antifungal or antibacterial compositions.Type: ApplicationFiled: March 13, 2013Publication date: January 29, 2015Applicant: Yale UniversityInventors: Ronald R. Breaker, Sanshu Li
-
Publication number: 20150017260Abstract: A nutritional supplement composition for treating nutritional deficiencies caused by a medical condition in subjects is disclosed. The present application further discloses a method of using a nutritional supplements composition for treating a subject with complications resulting from sickle cell anemia. The method comprises administering to a subject an effective amount of the nutritional supplement.Type: ApplicationFiled: July 28, 2014Publication date: January 15, 2015Inventors: Jacqueline M. Hibbert, Jonathan K. Stiles, Kayellen Umeakunne, Hyacinth I. Hyacinth
-
Publication number: 20140356424Abstract: The present invention relates to the field of food and medicines for the treatment or alleviation of premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), premenopause, menopause and female hormonal disorders. A first embodiment relates to a composition containing vitamins, minerals and oils. Additionally, the invention comprises a pharmaceutical form, more specifically in the form of soft capsules (also known as gelatin) containing the composition of the invention. In particular, the compositions of the invention contain vitamins and minerals in sources compatible with the association of vegetable oils, preferably borage oil, evening primrose oil, or a mixture of two oils, wherein the soft capsule contains a liquid and oily core.Type: ApplicationFiled: May 30, 2014Publication date: December 4, 2014Inventors: Wladia Möller VILAR, Thalita Piassa BARUFALDI, Silvana MASIERO, Rebecca Magalhães NADALUTI, Letícia Khater COVESI
-
Publication number: 20140348944Abstract: This invention relates to a “high lower alcohol content”(>40% v/v of a C1-4 alcohol) liquid composition able to be dispensed as a stable foam with the use of non-propellant foam dispensing devices from non-pressurized containers. The liquid compositions comprise an alcohol, C1-4 (>40% v/v), a silicone-based surfactant of at least 0.001% by weight to prepare a foamable composition, 0-10% w/w of additional minor components added to obtain the desired performance (a foamable composition), and the balance being purified water. The compositions may include emulsifier-emollients and moisturizers, secondary surfactants, foam stabilizers, fragrances, antimicrobial agents, other type of medicinal ingredients, and the like ingredients or additives or combinations thereof commonly added to alcohol gels or foams, aerosol compositions or to toiletries, cosmetics, pharmaceuticals and the like.Type: ApplicationFiled: February 24, 2014Publication date: November 27, 2014Applicant: Deb Worldwide Healthcare Inc.Inventors: Maria Teresa Fernandez de Castro, Bruce Michael Koivisto, Francisco Munoz
-
Publication number: 20140271558Abstract: Beta glucan and fulvic acid can be combined in a dietary supplement as a partial substitute or complete replacement for blue green algae and/or brown seaweed and its derivatives. Beta glucans are widely available as derivatives of Brewer's yeast and fulvic acid is widely available as well. These supplements are not subject to the vagaries of weather-influence growing seasons as is the case with blue green algae and brown seaweed. When combined, beta glucan and fulvic acid can provide a less costly dietary supplement than blue green algae and brown seaweed and its derivatives such as fucoidan.Type: ApplicationFiled: March 12, 2014Publication date: September 18, 2014Applicant: Cappellos, Inc.Inventor: John V. Cappello
-
Publication number: 20140271926Abstract: A method of treating neoplastic growth in a subject includes administering a glutamine synthetase (GS) inhibitor to the subject having neoplastic growth. A glutamine synthetase inhibitor may be administered in combination with thalidomide, lenalidomide and/or pomalidomide. Responsiveness to thalidomide, lenalidomide or pomalidomide therapy is determined by the expression levels of glutamine synthetase in neoplastic cells.Type: ApplicationFiled: March 12, 2014Publication date: September 18, 2014Inventors: Thang V. Nguyen, Raymond J. Deshaies
-
Publication number: 20140271529Abstract: Disclosed herein are antifungal compositions and methods of using the same to treat secondary skin and nail infections.Type: ApplicationFiled: March 13, 2014Publication date: September 18, 2014Applicant: ALC Therapeutics, LLCInventors: Martin STOGNIEW, Robert ALONSO, Joseph CAPRIOTTI, Kara CAPRIOTTI, Stuart LESSIN
-
Publication number: 20140271927Abstract: The present invention provides therapeutic and nutrient compositions comprising Alpha lipoic acid, gammalinolenic acid, chromium, selenium, and optionally iodine for the treatment of diabetic neuropaty. These compositions ameliorate the condition and symptoms associated with the complications of lack of triiodothyronine in the nucleus of target cells, in particular and the pathological effects of the vaso nervorum.Type: ApplicationFiled: March 13, 2014Publication date: September 18, 2014Inventor: Agustin Andrade
-
Publication number: 20140271925Abstract: A method and apparatus for producing aqueous iodine solutions to be used as a surface and aerosol disinfectant under continuous and dynamic flow conditions for medical applications comprises dissolving iodine into a first water flow thereby producing a concentrated aqueous iodine solution. The iodine solution is stored and then blended with a second water flow to produce a predetermined iodine disinfectant concentration of aqueous iodine. The disinfectant concentration is then stored and chemically adjusted to polarize to the species of iodine. The disinfectant concentration is then thermodynamically adjusted to maximize retention and disinfection variables. The iodine disinfectant is then ready to be used in an application requiring disinfection using iodine.Type: ApplicationFiled: March 12, 2014Publication date: September 18, 2014Applicant: NEET Innovations, LLCInventor: Terence F. MULLINS
-
Publication number: 20140234442Abstract: Disclosed is dental root canal filling (intracanal medicament) compositions that are effective against resistant root canal infections caused by Enterococcus faecalis and Vancomycin-resistant Enterococci.Type: ApplicationFiled: September 17, 2012Publication date: August 21, 2014Inventor: Rajdeep S. Pavaskar
-
Publication number: 20140205559Abstract: Improvements in or relating to manually operated dispense heads for fluid containersType: ApplicationFiled: May 8, 2012Publication date: July 24, 2014Applicant: ALC THERAPEUTICS, LLCInventors: Joseph Capriotti, Kara Capriotti
-
Publication number: 20140193371Abstract: A method for preventing and treating one or more disease states including the steps of altering the diet of an individual and then administering a drug to the individual. Plasma vitamin C level is reduced from a first level to a second level that is lower than the first level, such that a pharmacological response of the body of the individual to a drug at the first level is different from the pharmacological response of the body of said individual to the drug at the second level.Type: ApplicationFiled: January 7, 2014Publication date: July 10, 2014Inventor: Harold Edward Siess
-
Patent number: 8753692Abstract: The present invention provides novel compositions comprising: (a) protamine sulfate and (b) benzalkonium chloride or a silver containing particle; or (a) sodium metaperiodate and (b) 5-fluorouracil or chlorhexidine and uses thereof for the preparation of devices, and in particular medical devices, susceptible to colonization by biofilm forming bacteria.Type: GrantFiled: January 22, 2010Date of Patent: June 17, 2014Assignee: Kane Biotech Inc.Inventors: Purushottam V. Gawande, Srinivasa Madhyastha, Karen Lovetri, Nandadeva Yakandawala, Gord Froehlich
-
Patent number: 8691286Abstract: A composition for dissolving or reducing the viscosity of sputum on a surface of a device includes an effective amount of glycerol and an effective amount of dextran sulfate in a saline solution. The effective amount of glycerol is between about 30-50% and the effective amount of dextran sulfate is between about 10-30%. The composition may further include an antimicrobial agent.Type: GrantFiled: January 26, 2010Date of Patent: April 8, 2014Assignee: Teleflex Medical IncorporatedInventors: Nisha Gupta, Erin Peters, Joel Rosenblatt
-
Patent number: 8691290Abstract: A method for killing or substantially eradicating a pathogen in the upper respiratory tract of a mammal is disclosed. The method comprises generating molecular iodine (I2) in situ using an oxidant-reductant reaction with a minimum concentration of at least about 25 ppm of I2 and I2 comprises at least 40% of the total iodine atoms. A method for inhibiting superantigens using molecular iodine is also disclosed.Type: GrantFiled: October 15, 2012Date of Patent: April 8, 2014Assignee: Iogen LLCInventors: Jack Howard Kessler, James Carlton Richards
-
Patent number: 8679515Abstract: Contaminants are filtered from a fluid flow stream and the filter is regenerated by a process including steps of: providing a filter material comprising both carbon and potassium iodide; passing a contaminated fluid stream in contact with the filter material; adsorbing contaminants from the fluid stream onto surfaces in the filter material; passing an electric current through the filter material with adsorbed contaminant thereon; disassociating contaminant from the surfaces of the filter material; and removing disassociated contaminant from the filter material by carrying away the disassociated contaminant in a fluid flow mass. Separately, a stable, active iodine solution is also provided for numerous deodorizing and disinfecting applications.Type: GrantFiled: May 18, 2012Date of Patent: March 25, 2014Assignee: Biolargo Life Technologies, Inc.Inventors: Kenneth R. Code, Joseph Provenzano
-
Publication number: 20140044685Abstract: Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional compositions may provide for retention of lean body mass, which helps to avoid loss of independence and functionality, as well as to improve quality of life especially in the elderly at risk of sarcopenia and frailty. The nutritional compositions include ?-hydroxyisocaproic acid and citrulline. The composition may include other functional ingredients such as, but not limited to whey protein including whey protein micelles, prebiotic fibers, ?-keto-glutarate, eicosapentaenoic acid, L-carnitine, nucleotides, and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.Type: ApplicationFiled: April 18, 2012Publication date: February 13, 2014Applicant: NESTEC S.A.Inventors: Norman Alan Greenberg, Denis Breuille, Zamzam Kabiry (Fariba) Roughead, Doug Bolster, Jennifer Mager
-
Patent number: 8642057Abstract: Antimicrobial solutions and delivery systems for them use liquid antimicrobial solutions with: at least 80% of total weight of a carrier liquid comprising water, alcohol or a mixture of water and alcohol; at least 0.0001% by weight of the solution of I2; at least 0.0001% by weight of CuSO4; and sufficient acid in the solution top provide a pH of less than 7.0. A buffering system is also preferable in the solution, and the solution may be provided directly as a liquid, as a spray, as a gel, imbibed and carried in a wipe, encapsulated solution, segregated droplets of solution (in carrying layers of particles, dispersed in a solid of gel carrier) and the like.Type: GrantFiled: November 30, 2011Date of Patent: February 4, 2014Assignee: Biolargo Life Technologies, Inc.Inventors: Kenneth R. Code, Joseph L. Provenzano, Richard D. Bickerstaff
-
Publication number: 20140030241Abstract: Nutritional compositions having dietary nucleotides, ?-3 fatty acids and citrulline are provided. The nutritional compositions may be formulated to improve T cell function, increase arginine availability in vivo, regulate myeloid-derived suppressor cells (“MDSC”), and decrease the risk and/or severity of infection after surgery or trauma. Methods of making, using and administering such nutritional compositions to individuals in need of same are also provided. Methods for modulating the affects of MDSC's are also provided.Type: ApplicationFiled: March 15, 2012Publication date: January 30, 2014Applicant: NESTEC S.A.Inventor: Norman Alan Greenberg
-
Publication number: 20140023728Abstract: A iodine liquid soap dispenser having a reservoir containing an iodine solution. The dispenser has a head communicating with the reservoir capable of delivering the solution to the exterior of the reservoir in the form of foam. The solution comprises water, iodine and iodide, and contains iodine in a range of concentration between 0.35% and 0.05% by weight of the solution. The solution may also contain one or more of the following: an anionic surfactant, Hydrogen Iodide, glycerine, and sodium hydroxide.Type: ApplicationFiled: July 20, 2012Publication date: January 23, 2014Inventor: David Ricketts, SR.
-
Publication number: 20140010881Abstract: Iodine-containing germicidal compositions are disclosed that remain physically stable for extended storage periods with little to no iodine complexing agent being present. The compositions employ a mixture of emollients, such as glycerin and ethoxylanolin, to create a composition that in certain embodiments presents a cloudy or emulsion-like appearance.Type: ApplicationFiled: March 23, 2012Publication date: January 9, 2014Applicant: DELAVAL HOLDING ABInventor: Mark Henderson
-
Publication number: 20140005616Abstract: Single layer and multi-layer anti-microbial wound care fabrics, gloves, sleeves, anklets, socks, finger cots, masks, and similar wound care articles are disclosed.Type: ApplicationFiled: June 27, 2013Publication date: January 2, 2014Applicant: Ansell LimitedInventors: JEFFREY MORELAND, ROGER EUGENE HUCKFELDT, DION ROSS, ERIC THOMPSON, JAMIE ASHWORTH, MICHAEL ZEDALIS, ANTHONY B. LOPEZ
-
Patent number: 8574610Abstract: An article or material is applied to the environment of the body of an animal (including humans) to provide both absorbency and antimicrobial activity. The article or material may comprise a water absorbent material; and a composition that reacts with water to produce molecular iodine. The composition provides a local concentration (in the water) of at least 10 parts per million iodine in water carried by the material (that is actual water supported by the water absorbent material) when the material has 5% by weight of water present in the water absorbent. The material may be a flowable material, or the article may be diaper, sanitary pad, bandage, adhesive pad or wrap for an animal.Type: GrantFiled: January 10, 2011Date of Patent: November 5, 2013Assignee: Biolargo Life Technologies, Inc.Inventor: Kenneth R. Code
-
Publication number: 20130287865Abstract: Antimicrobial solutions and delivery systems for them use liquid antimicrobial solutions with: at least 80% of total weight of a carrier liquid comprising water, alcohol or a mixture of water and alcohol; at least 0.0001% by weight of the solution of I2; at least 0.0001% by weight of CuSO4; and sufficient acid in the solution top provide a pH of less than 7.0. A buffering system is also preferable in the solution, and the solution may be provided directly to wounds, burns or other skin damage as a liquid, as a spray or as a gel.Type: ApplicationFiled: March 15, 2013Publication date: October 31, 2013Applicant: BIOLARGO LIFE TECHNOLOGIES, INC.Inventors: Kenneth R. Code, Joseph Provenzano, Richard D. Bickerstaff
-
Publication number: 20130259917Abstract: Antiseptic compounds that act as persistent and fast acting antiseptics and disinfectants. The base of these antiseptic actions is CaF2 as the persistent part, preventing the colonization of tissue and nonliving surfaces with microorganisms through the targeted on-demand release of fluorine ions. For fighting heavy contamination and invasion of transient microbes through new application of the solution, fast acting alcohols and toxic solutions have been added in small percentage. They act fast and evaporate fast, leaving the natural protection of skin undamaged and coated with a persistent antiseptic.Type: ApplicationFiled: May 20, 2013Publication date: October 3, 2013Inventors: Fridolin Voegeli, Frank Flechsig, Thomas Flechsig
-
Publication number: 20130209581Abstract: The present invention relates to the use of iodinated activated charcoal, optionally in combination with a bromide salt, in treatment of one or more symptom(s) caused by depression, wherein said symptom(s) is/are selected from the group consisting depressive mood, emotional fatigue, mental fatigue which can be chronic, burnout, withdrawal from social situations, anxiety, concentration problems, unpleasant heart palpitations, irregular heart beats, a feeling of pressure in the chest, irritable bowel syndrome and sexual dysfunction.Type: ApplicationFiled: June 21, 2011Publication date: August 15, 2013Applicant: PHARMALUNDENSIS ABInventor: Staffan Skogvall
-
Publication number: 20130209582Abstract: To propose a health food or a drug, which comprises an iodine compound as a substitute for organic iodine and can exert a similar effect as organic iodine. To propose a method for producing a liquid to be used as a starting material for the aforesaid health food or drug. A health food and a drug each containing hydrogen iodide as the active ingredient. A method for producing a hydrogen iodide-containing solution, which comprises: an alkaline ion water preparation step for preparing alkaline ion water containing hydrogen peroxide; a sodium hydroxide production step for adding sodium to the alkaline ion water and thus producing sodium hydroxide; and a hydrogen iodide production step for, after the sodium hydroxide production step, adding iodine to the alkaline ion water and thus producing hydrogen iodide.Type: ApplicationFiled: September 27, 2010Publication date: August 15, 2013Inventor: Kazuyoshi Sato
-
Publication number: 20130183277Abstract: Provided are compositions and methods for increasing patient CD4+ cell count while undergoing treatment for immune-mediated disease, cancer, heart disease, neurodegenerative disease, or infectious disease by administering to the patient a nutrient composition including, inter alia, alpha lipoic acid, acetyl L-carnitine, and N-acetyl-cysteine.Type: ApplicationFiled: December 19, 2012Publication date: July 18, 2013Inventor: Jon D. Kaiser
-
Publication number: 20130122115Abstract: A specifically formulated composition comprised of Magnesium Sulfate (Epsom salt), Triodine-7 Solution (about 2% Iodine tincture, Potassium Iodide and Povidone Iodine), Arnica Montana 30x, and Pine Tar for the treatment of horse hoof soreness, Inflammation, and Infection (including abscesses). The formula contains specific amounts of each ingredient to pull out the infection while maintaining proper moisture balance in the hoof. This composition includes a sugar wax tackifier which creates an extremely sticky composition that sticks to the underside of the hoof WITHOUT WRAPPING, enabling the composition to be applied in 25 seconds rather than the 25 minutes it would take to mix a solution with all the ingredients and then wrapping the hoof with a diaper, vet wrap and duct tape to keep everything in place.Type: ApplicationFiled: November 16, 2011Publication date: May 16, 2013Inventor: Ashley Kehoe
-
Publication number: 20130108683Abstract: The present invention provides compositions and methods for treating deep partial thickness or full thickness wounds or injuries. The present invention also provides compositions and methods for promoting healing and regeneration of impaired or damaged tissue at a site of such partial thickness or full thickness wounds or injuries, as well as promoting vascularization and angiogenesis in regenerating and/or supportive tissue at such sites.Type: ApplicationFiled: October 24, 2012Publication date: May 2, 2013Applicant: BIOMIMETIC THERAPEUTICS, INC.Inventor: BioMimetic Therapeutics, Inc.
-
Publication number: 20130084272Abstract: The present invention relates to compositions, kits and methods for the administration of compositions and kits for supplementation with twelve carbon chain fatty acids or twelve carbon chain acylglycerols; and specifically for the supplementation with twelve carbon chain fatty acids such as lauric acid and twelve carbon chain acylglycerols such as monolaurin; and specifically for the co-supplementation with other vitamins, minerals and nutrients.Type: ApplicationFiled: September 29, 2011Publication date: April 4, 2013Inventors: Philippe PERRIN, Guillaume HERRY, Cecile BOYER-JOUBERT
-
Patent number: 8404281Abstract: Nanoparticles comprising T3 and their use in treating, e.g., cardiac conditions, for example cardiac arrest, are provided. Such nanoparticles provide improved delivery of T3 and allow for acute treatment and optionally for sustained release of T3 in a patient.Type: GrantFiled: June 8, 2010Date of Patent: March 26, 2013Assignee: Avant Garde Therapeutics & Technologies LLCInventors: Leo Rubin, Shaker Mousa
-
Publication number: 20130064809Abstract: A composition for prophylactic and/or therapeutic medicinal applications, or plant protection applications, in particular for the control of microorganisms, either planktonic or organized in biofilms. The composition includes at least one ion selected from hypohalite, at least one compound selected from lactoferrin, lactoferrin peptide, lysozyme, immunoglobulins or a combination thereof, optionally hypothiocyanite, and optionally at least one growth factor.Type: ApplicationFiled: August 6, 2012Publication date: March 14, 2013Inventor: Jean-Paul PERRAUDIN
-
Publication number: 20130052278Abstract: The present disclosure provides a rapidly disintegrating orally administrable powder. The powder may include an active ingredient such as a dietary supplement. Methods of using the same are also provided herein.Type: ApplicationFiled: March 10, 2011Publication date: February 28, 2013Applicant: RICH VITAMINS LLCInventors: Hallie N. Rich, Michelle G. Cannon
-
Publication number: 20130045183Abstract: The present disclosure relates to non-acidic extracts or fractions selected from a Boswellia low polar gum resin extract fraction (BLPRE), a Boswellia volatile oil fraction (BVOIL), and a Boswellia oil fraction (BOIL) and their compositions. BLPRE, BOIL, and BVOIL are each derived from the gum resin of a Boswellia species. These compositions are useful for improving mental condition, enhancing brain functions such as cognition, memory, learning, communication and brain health, for treating impaired memory, and for preventing, control or treating memory and cognition related disorders/diseases. Additionally, BOIL, BVOIL, and mixtures of BOIL and BVOIL are useful for enhancing the bioavailability of a biological agent.Type: ApplicationFiled: September 14, 2012Publication date: February 21, 2013Applicant: LAILA NUTRACEUTICALSInventors: Ganga Raju GOKARAJU, Rama Raju GOKARAJU, Venkata Kanaka Ranga Raju GOKARAJU, Trimurtulu GOLAKOTI, Kiran BHUPATHIRAJU, Venkata Krishna Raju ALLURI
-
Patent number: 8377482Abstract: The invention discloses a trace element solution, which comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium; and at least one component selected from the group comprising a vitamin, a vaccine, a growth stimulant, a dewormer, iron dextran, an antibiotic and a synchronization preparation. The synchronization preparation is a combination of injectable hormonal preparations, inplantable hormonal preparations, intravaginal hormonal preparation and other slow release hormonal preparation. The antibiotics include oral, injectable and implantable theurapeutic remedies. The vaccine includes antigens and a combination of antigens and adjuvents. The growth stimulants include zeranol, estradiol, testosterone, progesterone and trenbolone acetate. The dewormer includes macrocydic lactones, leramizoles, benzimidazoles and salicylanilides. The macrocydic lactones include doramectin, ivermectin, abamectin and moxidectin.Type: GrantFiled: September 7, 2005Date of Patent: February 19, 2013Assignee: Warburton Technology LimitedInventors: Robert N. Laurie, William A. Smith
-
Publication number: 20130039968Abstract: The invention provides a novel method of generating fabrics with outstanding antitoxic properties. The antitoxic properties are imparted to the fabric by introducing an active agent such as an antimicrobial or antiviral agent to the fabric. The active agent may be introduced into the fabric at multiple stages of the manufacturing process. For nonwoven fabrics, the active agent can be introduced during web formation and/or during post-processing steps. The fabrics produced in accordance with the present invention have widespread utility. For instance, they can be used as wound dressings, gowns, drapes, air filters, protective clothing and wipes.Type: ApplicationFiled: February 22, 2011Publication date: February 14, 2013Applicant: TRIOMED INNOVATIONS CORP.Inventors: Pierre Jean Messier, David Ohayon
-
Publication number: 20130039953Abstract: A method for treating a surface with a therapeutic agent is disclosed. The method comprises precipitating a therapeutic agent from a hydrophilic polymeric base layer with which the therapeutic agent has been complexed, to form a layer comprising microparticles of the therapeutic agent on the hydrophilic polymeric base layer, the hydrophilic polymeric base layer being grafted to the surface. Devices comprising a surface having a hydrophilic polymeric base layer comprising a hydrophilic polymer grafted to the surface and a layer comprising microparticles of a therapeutic agent disposed on and complexed with the hydrophilic polymeric base layer are also disclosed.Type: ApplicationFiled: July 6, 2012Publication date: February 14, 2013Applicant: Covalon TechnologiesInventors: Vyacheslav Dudnyk, Valerio DiTizio
-
Publication number: 20130011490Abstract: This invention relates to a “high lower alcohol content” (>40% v/v of a C1-4 alcohol) liquid composition able to be dispensed as a stable foam with the use of non-propellant foam dispensing devices from non-pressurized containers. The liquid compositions comprise an alcohol, C1-4 (>40% v/v), a silicone-based surfactant of at least 0.001% by weight to prepare a foamable composition, 0-10% w/w of additional minor components added to obtain the desired performance (a foamable composition), and the balance being purified water. The compositions may include emulsifier-emollients and moisturizers, secondary surfactants, foam stabilizers, fragrances, antimicrobial agents, other type of medicinal ingredients, and the like ingredients or additives or combinations thereof commonly added to alcohol gels or foams, aerosol compositions or to toiletries, cosmetics, pharmaceuticals and the like.Type: ApplicationFiled: September 10, 2012Publication date: January 10, 2013Applicant: DEB WORLDWIDE HEALTHCARE INC.Inventors: Maria Teresa Fernandez de Castro, Bruce Michael Koivisto, Francisco Munoz